# Bristol Myers Squibb Co: filings

BMY · NYSE · CIK 14272 · [Healthcare](/sectors/healthcare.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/bmy.md) · [Financials](/companies/bmy/financials.md) · [Filings](/companies/bmy/filings.md) · [Insiders](/companies/bmy/insiders.md)

## Reports and events: 353 filings

Newest first, by EDGAR acceptance time (Eastern). Filter with ?form= one of: `periodic`, `8-K`, `10-K`, `10-Q`, `4`, `proxy`, `13dg`, `all`, or any form this company filed (4 1591, 8-K 248, 4/A 72, 425 65, 3 60, 11-K 54, 10-Q 53, CORRESP 44, SC 13G/A 43, SC TO-T/A 38, DEFA14A 34, UPLOAD 34, NO ACT 21, 10-K 18, DEF 14A 18, SC TO-C 15, SC 13G 14, ARS 11, DFAN14A 10, 3/A 9, 424B3 9, 424B5 9, 5 9, FWP 9, 144 8, SC TO-T 8, CT ORDER 6, S-3ASR 6, SC 13D/A 6, SC TO-I/A 6, 8-K/A 5, PRE 14A 5, PX14A6G 5, S-8 5, SCHEDULE 13G/A 5, 8-A12B 4, SC 13D 4, CERT 3, SCHEDULE 13G 3, 25-NSE 2, 424B2 2, EFFECT 2, S-4 2, S-4/A 2, S-8 POS 2, 10-K/A 1, 15-12G 1, 25 1, 25-NSE/A 1, 8-A12G 1, CERTNYS 1, DEFC14A 1, POSASR 1, PREC14A 1, PRRN14A 1, SC TO-I 1).

| Filed | Accepted | Form | What it is | Accession |
| --- | --- | --- | --- | --- |
| 2026-10-29 | 07:05 ET | [8-K](/filings/0000014272-26-000022.md) | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0000014272-26-000022 |
| 2026-07-30 | 11:10 ET | [10-Q](/filings/0000014272-26-000020.md) | Quarterly report, period 2026-06-30 | 0000014272-26-000020 |
| 2026-07-30 | 07:05 ET | [8-K](/filings/0000014272-26-000018.md) | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0000014272-26-000018 |
| 2026-05-08 | 16:10 ET | [8-K](/filings/0001140361-26-020036.md) | 5.07 Shareholder vote results | 0001140361-26-020036 |
| 2026-04-30 | 11:44 ET | [10-Q](/filings/0000014272-26-000010.md) | Quarterly report, period 2026-03-31 | 0000014272-26-000010 |
| 2026-04-30 | 07:01 ET | [8-K](/filings/0000014272-26-000008.md) | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0000014272-26-000008 |
| 2026-03-25 | 16:19 ET | [DEF 14A](/filings/0000014272-26-000006.md) | Proxy statement, period 2026-05-05 | 0000014272-26-000006 |
| 2026-02-11 | 11:35 ET | [10-K](/filings/0000014272-26-000004.md) | Annual report, period 2025-12-31 | 0000014272-26-000004 |
| 2026-02-05 | 07:07 ET | [8-K](/filings/0000014272-26-000002.md) | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0000014272-26-000002 |
| 2026-01-12 | 10:20 ET | [8-K](/filings/0001140361-26-000929.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001140361-26-000929 |
| 2025-11-18 | 16:41 ET | [8-K](/filings/0001140361-25-042607.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001140361-25-042607 |
| 2025-11-10 | 16:06 ET | [8-K](/filings/0001140361-25-041380.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001140361-25-041380 |
| 2025-11-03 | 06:09 ET | [8-K](/filings/0001140361-25-040066.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001140361-25-040066 |
| 2025-10-30 | 12:04 ET | [10-Q](/filings/0000014272-25-000149.md) | Quarterly report, period 2025-09-30 | 0000014272-25-000149 |
| 2025-10-30 | 07:09 ET | [8-K](/filings/0000014272-25-000147.md) | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0000014272-25-000147 |
| 2025-07-31 | 12:17 ET | [10-Q](/filings/0000014272-25-000131.md) | Quarterly report, period 2025-06-30 | 0000014272-25-000131 |
| 2025-07-31 | 07:06 ET | [8-K](/filings/0000014272-25-000129.md) | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0000014272-25-000129 |
| 2025-07-25 | 16:43 ET | [8-K](/filings/0001140361-25-027350.md) | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001140361-25-027350 |
| 2025-05-07 | 17:04 ET | [8-K](/filings/0001140361-25-017742.md) | 5.07 Shareholder vote results | 0001140361-25-017742 |
| 2025-04-24 | 11:45 ET | [10-Q](/filings/0000014272-25-000091.md) | Quarterly report, period 2025-03-31 | 0000014272-25-000091 |
| 2025-04-24 | 07:11 ET | [8-K](/filings/0000014272-25-000089.md) | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0000014272-25-000089 |
| 2025-03-26 | 16:18 ET | [DEF 14A](/filings/0000014272-25-000075.md) | Proxy statement, period 2024-12-31 | 0000014272-25-000075 |
| 2025-02-18 | 16:35 ET | [8-K](/filings/0001140361-25-005012.md) | 5.02 Departure or appointment of officers or directors | 0001140361-25-005012 |
| 2025-02-12 | 12:52 ET | [10-K](/filings/0000014272-25-000039.md) | Annual report, period 2024-12-31 | 0000014272-25-000039 |
| 2025-02-06 | 07:46 ET | [8-K](/filings/0000014272-25-000037.md) | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0000014272-25-000037 |
| 2025-01-13 | 10:20 ET | [8-K](/filings/0001140361-25-000885.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001140361-25-000885 |
| 2024-10-31 | 11:43 ET | [10-Q](/filings/0000014272-24-000147.md) | Quarterly report, period 2024-09-30 | 0000014272-24-000147 |
| 2024-10-31 | 07:52 ET | [8-K](/filings/0000014272-24-000145.md) | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0000014272-24-000145 |
| 2024-07-26 | 12:04 ET | [10-Q](/filings/0000014272-24-000123.md) | Quarterly report, period 2024-06-30 | 0000014272-24-000123 |
| 2024-07-26 | 07:46 ET | [8-K](/filings/0000014272-24-000121.md) | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0000014272-24-000121 |
| 2024-06-18 | 16:23 ET | [8-K](/filings/0001140361-24-030533.md) | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001140361-24-030533 |
| 2024-05-09 | 16:53 ET | [8-K](/filings/0001140361-24-025213.md) | 5.03 Amendment to articles or bylaws; 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0001140361-24-025213 |
| 2024-04-25 | 12:38 ET | [10-Q](/filings/0000014272-24-000096.md) | Quarterly report, period 2024-03-31 | 0000014272-24-000096 |
| 2024-04-25 | 07:47 ET | [8-K](/filings/0000014272-24-000094.md) | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0000014272-24-000094 |
| 2024-03-28 | 17:16 ET | [DEF 14A](/filings/0001140361-24-016251.md) | Proxy statement, period 2024-05-07 | 0001140361-24-016251 |
| 2024-03-18 | 17:30 ET | [8-K](/filings/0001140361-24-013978.md) | 5.02 Departure or appointment of officers or directors | 0001140361-24-013978 |
| 2024-03-18 | 08:56 ET | [8-K](/filings/0001140361-24-013726.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001140361-24-013726 |
| 2024-02-22 | 16:15 ET | [8-K](/filings/0001140361-24-009040.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001140361-24-009040 |
| 2024-02-15 | 16:57 ET | [8-K](/filings/0001140361-24-008198.md) | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001140361-24-008198 |
| 2024-02-14 | 16:32 ET | [8-K](/filings/0001140361-24-008013.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001140361-24-008013 |
| 2024-02-13 | 11:54 ET | [10-K](/filings/0000014272-24-000044.md) | Annual report, period 2023-12-31 | 0000014272-24-000044 |
| 2024-02-02 | 07:46 ET | [8-K](/filings/0000014272-24-000020.md) | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0000014272-24-000020 |
| 2024-01-08 | 10:29 ET | [8-K](/filings/0001140361-24-001288.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001140361-24-001288 |
| 2023-12-22 | 16:15 ET | [8-K](/filings/0001140361-23-059159.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001140361-23-059159 |
| 2023-11-13 | 16:19 ET | [8-K](/filings/0001140361-23-052908.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001140361-23-052908 |
| 2023-10-31 | 16:30 ET | [8-K/A](/filings/0001140361-23-050518.md) | 5.02 Departure or appointment of officers or directors | 0001140361-23-050518 |
| 2023-10-26 | 12:33 ET | [10-Q](/filings/0000014272-23-000181.md) | Quarterly report, period 2023-09-30 | 0000014272-23-000181 |
| 2023-10-26 | 07:44 ET | [8-K](/filings/0000014272-23-000179.md) | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0000014272-23-000179 |
| 2023-08-10 | 07:10 ET | [8-K](/filings/0001140361-23-038900.md) | 8.01 Other events | 0001140361-23-038900 |
| 2023-07-27 | 12:28 ET | [10-Q](/filings/0000014272-23-000152.md) | Quarterly report, period 2023-06-30 | 0000014272-23-000152 |

Page 1 of 8. [Older](/companies/bmy/filings.md?page=2)
Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Oct 29, 2026, 11:17 ET. No prices; not investment advice.